Our findings suggest that under the inhibitory effect of an EGFR TKI, HGF-mediated PIP3 activation may bypass EGFR-mediated PIP3 activation, an observation further supported by elevated HGF expression in tumors with higher tumor-stroma interactions. Here, EGFR is linked to neoplasm.